Log in
Home
Data and Resources
Biomarkers
Data
EDRN Common Data Elements (CDEs)
Informatics
Protocols
Publications
Data and Specimen Reference Sets
Standard Operating Procedures
Statistical Resources
Submitting and Sharing Data
Work with EDRN
Advocacy Groups
Associate Membership Program
Funding Opportunities
Member Finder
Propose a Validation Study
Public-Private Partnerships
Memoranda of Understanding
News and Events
EDRN Newsletter
Upcoming Meetings
Meeting Reports
Webinars
About EDRN
Mission and Structure
FDA-Approved Tests
CLIA-Approved Markers
Five-Phase Approach and Prospective specimen collection, Retrospective Blinded Evaluation Study Design
Informatics and Data Science
History of the EDRN
Bookshelf
Sites
Committees and Collaborative Groups
Search
Search
EDRN
Data and Resources
Publications
Interpreting the evidence base for fruquintinib in refractory metastatic colorectal cancer.
Interpreting the evidence base for fruquintinib in refractory metastatic colorectal cancer.
Abstract
No abstract available.
EDRN PI Authors
Bresalier, Bob
Medline Author List
Shaukat A
Udaikumar J
PubMed ID
42169893
Appears In
J Gastrointest Oncol, 2026 Apr (issue 2)
